Drug Guide

Generic Name

Fexofenadine Hydrochloride

Brand Names Allegra, Children's Allegra Allergy, Children's Allegra Hives, Allegra Allergy, Allegra Hives, Children's Fexofenadine Hydrochloride Allergy, Children's Fexofenadine Hydrochloride Hives, Fexofenadine Hydrochloride Allergy, Fexofenadine Hydrochloride Hives

Classification

Therapeutic: Antihistamine for allergy relief

Pharmacological: Second-generation H1 antihistamine

FDA Approved Indications

Mechanism of Action

Fexofenadine antagonizes peripheral H1 histamine receptors, reducing allergy symptoms without significant sedative effects.

Dosage and Administration

Adult: 60 mg twice daily or 180 mg once daily

Pediatric: 30 mg twice daily for children 2-11 years; 60 mg twice daily for children 12 years and older

Geriatric: No specific dose adjustment necessary; start with lowest dose if renal impairment present

Renal Impairment: Reduce dose in moderate to severe renal impairment (creatinine clearance ≤ 60 mL/min)

Hepatic Impairment: No specific dose adjustment required

Pharmacokinetics

Absorption: Rapidly absorbed, peak plasma levels in 1-3 hours

Distribution: Low volume of distribution; approximately 60% bound to plasma proteins

Metabolism: Limited hepatic metabolism; mainly excreted unchanged

Excretion: Primarily in feces (70%) and urine (20%)

Half Life: 14 hours

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for relief of allergy symptoms and adverse reactions.

Diagnoses:

  • Impaired skin integrity related to allergic reaction
  • Risk for side effects related to medication use

Implementation: Administer as directed; educate patient on timing and interactions.

Evaluation: Assess symptom relief and monitor for adverse effects.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: None specified

Lab Test Interference: No known interference with lab tests

Overdose Management

Signs/Symptoms: Drowsiness, dizziness, dry mouth, headache, nausea

Treatment: Supportive care; activated charcoal if ingestion recent; symptomatic treatment as needed.

Storage and Handling

Storage: Store at room temperature, 20-25°C (68-77°F).

Stability: Stable until expiration date.

This guide is for educational purposes only and is not intended for clinical use.